Table 2.

Retrospective priapism characteristics of a cohort of men with sickle cell anemia enrolled in the priapism study (n = 73)

CharacteristicSummary statistics
Age at first priapism event, mean (SD) 18.7 (4.3) 
Priapism events in the past 12 mo, median (IQR) 8.0 (4.0-25.0) 
Duration of priapism event (min), median (IQR) 120.0 (45.0-180.0) 
Priapism triggers, n (%) 
Sleep 38 (52.1) 
Sexual urge 18 (24.7) 
Dehydration 4 (5.5) 
Fever 4 (5.5) 
Drugs 1 (1.4) 
Other 6 (8.2) 
Don't know 19 (26.0) 
Location of priapism pain, n (%) 
All over the penis 40 (54.8) 
Penis shaft 20 (27.4) 
Whole perineum 7 (9.6) 
Glans penis 6 (8.2) 
Nature of priapism pain, n (%) 
Piercing 35 (47.9) 
Throbbing 28 (38.4) 
Burning 25 (34.2) 
Cramping 10 (13.7) 
Crushing 9 (12.3) 
Stabbing 4 (5.5) 
Other 3 (4.1) 
Priapism pain on a scale from 1 (mild) to 10 (excruciating/ worst possible), median (IQR) 7.0 (5.0-8.0) 
Priapism pain radiates to other parts of the body, n (%) 5 (6.8) 
When pain radiates, to what other parts of the body, n (%); n = 5 
Abdomen 2 (40.0) 
Hip 1 (20.0) 
Thigh 1 (20.0) 
Other 1 (20.0) 
Coping mechanisms that relieve priapism events at home, n (%) 
Exercise 44 (60.3) 
Cold shower 25 (34.2) 
Hot shower 11 (15.1) 
Ice pack 3 (4.1) 
Analgesics 3 (4.1) 
Other 3 (4.1) 
None 11 (15.1) 
Sought medical treatment for priapism in the past 12 mo, n (%) 25 (34.2) 
Which medical treatment(s) worked, n (%); n = 25 
Stilbesterol 6 (24.0) 
Analgesics 6 (24.0) 
Hydroxyurea 3 (12.0) 
None 12 (48.0) 
Penile aspiration in the past 12 mo, n (%) 2 (2.7) 
Surgical shunt in the past 12 mo, n (%) 1 (1.4) 
Medications currently on for priapism, n (%); n = 71 
Stilbesterol 5 (7.1) 
Hydroxyurea 3 (4.3) 
Analgesics 2 (2.9) 
None 61 (87.1) 
Any priapism associated with vaso-occlusive pain, n (%); n = 72 11 (15.3) 
If associated, when did the vaso-occlusive pain occur, n (%); n = 11 
Just before priapism 4 (36.4) 
Along with priapism 3 (27.3) 
Immediately after priapism 4 (36.4) 
How does priapism pain compare with typical pain crisis, n (%) 
Better 41 (56.2) 
Similar 15 (20.5) 
Worse 17 (23.3) 
CharacteristicSummary statistics
Age at first priapism event, mean (SD) 18.7 (4.3) 
Priapism events in the past 12 mo, median (IQR) 8.0 (4.0-25.0) 
Duration of priapism event (min), median (IQR) 120.0 (45.0-180.0) 
Priapism triggers, n (%) 
Sleep 38 (52.1) 
Sexual urge 18 (24.7) 
Dehydration 4 (5.5) 
Fever 4 (5.5) 
Drugs 1 (1.4) 
Other 6 (8.2) 
Don't know 19 (26.0) 
Location of priapism pain, n (%) 
All over the penis 40 (54.8) 
Penis shaft 20 (27.4) 
Whole perineum 7 (9.6) 
Glans penis 6 (8.2) 
Nature of priapism pain, n (%) 
Piercing 35 (47.9) 
Throbbing 28 (38.4) 
Burning 25 (34.2) 
Cramping 10 (13.7) 
Crushing 9 (12.3) 
Stabbing 4 (5.5) 
Other 3 (4.1) 
Priapism pain on a scale from 1 (mild) to 10 (excruciating/ worst possible), median (IQR) 7.0 (5.0-8.0) 
Priapism pain radiates to other parts of the body, n (%) 5 (6.8) 
When pain radiates, to what other parts of the body, n (%); n = 5 
Abdomen 2 (40.0) 
Hip 1 (20.0) 
Thigh 1 (20.0) 
Other 1 (20.0) 
Coping mechanisms that relieve priapism events at home, n (%) 
Exercise 44 (60.3) 
Cold shower 25 (34.2) 
Hot shower 11 (15.1) 
Ice pack 3 (4.1) 
Analgesics 3 (4.1) 
Other 3 (4.1) 
None 11 (15.1) 
Sought medical treatment for priapism in the past 12 mo, n (%) 25 (34.2) 
Which medical treatment(s) worked, n (%); n = 25 
Stilbesterol 6 (24.0) 
Analgesics 6 (24.0) 
Hydroxyurea 3 (12.0) 
None 12 (48.0) 
Penile aspiration in the past 12 mo, n (%) 2 (2.7) 
Surgical shunt in the past 12 mo, n (%) 1 (1.4) 
Medications currently on for priapism, n (%); n = 71 
Stilbesterol 5 (7.1) 
Hydroxyurea 3 (4.3) 
Analgesics 2 (2.9) 
None 61 (87.1) 
Any priapism associated with vaso-occlusive pain, n (%); n = 72 11 (15.3) 
If associated, when did the vaso-occlusive pain occur, n (%); n = 11 
Just before priapism 4 (36.4) 
Along with priapism 3 (27.3) 
Immediately after priapism 4 (36.4) 
How does priapism pain compare with typical pain crisis, n (%) 
Better 41 (56.2) 
Similar 15 (20.5) 
Worse 17 (23.3) 

SD, standard deviation.

More than 1 response allowed.

Close Modal

or Create an Account

Close Modal
Close Modal